Interaction between favipiravir and hydroxychloroquine and their combined drug assessment: in silico investigations

Hydroxychloroquine (HCQ) and favipiravir (FPV) are known to be effective antivirals, and there are reports about their use to fight the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) despite that these are not conclusive. The use of combined drugs is common in drug discovery, and thus,...

Descripción completa

Detalles Bibliográficos
Autores principales: Parlak, Cemal, Alver, Özgür, Ouma, Cecil Naphtaly Moro, Rhyman, Lydia, Ramasami, Ponnadurai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Versita 2021
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8562770/
https://www.ncbi.nlm.nih.gov/pubmed/34744292
http://dx.doi.org/10.1007/s11696-021-01946-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8562770/
https://www.ncbi.nlm.nih.gov/pubmed/34744292
http://dx.doi.org/10.1007/s11696-021-01946-8

Ejemplares similares